Publishing research using ab108341? Please let us know so that we can cite the reference in this datasheet.

ab108341 has been referenced in 17 publications.

  • Lee E  et al. GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance. Elife 8:N/A (2019). PubMed: 30644358
  • Liao Y  et al. Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination. Oncogene 37:1896-1910 (2018). Human . PubMed: 29353883
  • Puca L  et al. Patient derived organoids to model rare prostate cancer phenotypes. Nat Commun 9:2404 (2018). PubMed: 29921838
  • Savchuk I  et al. The human genital tubercle is steroidogenic organ at early pregnancy. Mol Cell Endocrinol 477:148-155 (2018). PubMed: 29928928
  • Solorzano SR  et al. GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: Contribution to prostate cancer progression. Sci Rep 8:10272 (2018). PubMed: 29980692
  • Blanco LZ  et al. Steroid hormone synthesis by the ovarian stroma surrounding epithelial ovarian tumors: a potential mechanism in ovarian tumorigenesis. Mod Pathol 30:563-576 (2017). PubMed: 28059101
  • Shukla S  et al. Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer Cell 32:792-806.e7 (2017). PubMed: 29153843
  • Hieronymus H  et al. Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis. Nat Commun 8:1081 (2017). PubMed: 29057879
  • Siu MK  et al. KLF4 functions as an activator of the androgen receptor through reciprocal feedback. Oncogenesis 5:e282 (2016). WB, IHC-P ; Human . PubMed: 27991915
  • Pinto F  et al. Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer. Oncotarget 7:28891-902 (2016). WB . PubMed: 27049720
  • Urbinati G  et al. Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide. Mol Ther Nucleic Acids 5:e301 (2016). PubMed: 27023109
  • Tong D  et al. The HIF/PHF8/AR axis promotes prostate cancer progression. Oncogenesis 5:e283 (2016). Human . PubMed: 27991916
  • Liu YN  et al. Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis. Mol Cell Biol 35:1940-51 (2015). ChIP ; Human . PubMed: 25802280
  • Yin J  et al. AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis. Cancer Res 74:4306-17 (2014). ChIP ; Human . PubMed: 24970477
  • Chen S  et al. Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL. Biochem J 456:55-66 (2013). PubMed: 23961993
  • Chen Y  et al. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat Med 19:1023-9 (2013). WB, IHC-P, ChIP ; Mouse . PubMed: 23817021
  • Kuhn E  et al. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer 49:3839-49 (2013). PubMed: 24012099

For licensing inquiries, please contact

Sign up